← Human Trials & Peer-Reviewed Studies
Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial.
Plain-language guide to PMID 16244538 (2005): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 41 adults.
Key Facts
- PMID
- 16244538
- Journal
- Annals of surgery
- Year
- 2005
- Study type
- Randomized Controlled Trial
- Authors
- Byrne TA et al. (9 authors)
- DOI
- 10.1097/01.sla.0000186479.53295.14
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Standard criteria based on clinical and laboratory measurements were followed to determine PN volume and content.
Why It Was Studied
Following massive intestinal resection, patients frequently sustain severe nutrient malabsorption and are dependent on PN for life.
Who Took Part
The study group was 41 adults.
PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.
A prospective, double-blind, randomized, placebo-controlled clinical trial performed in 41 adults dependent on PN.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.
Blinding on both sides kept the adults and researchers unaware of who received Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The comparison arm used a placebo, so changes seen with Exogenous HGH, sermorelin & older GHRPs (why they're passed over) could be set against what happens without it.
What Was Measured
Following massive intestinal resection, patients frequently sustain severe nutrient malabsorption and are dependent on PN for life.
PubMed files the paper under topics including Analysis of Variance, Combined Modality Therapy, Diet, Glutamine, Human Growth Hormone, Nutritional Requirements and Nutritional Status.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 41 adults.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2005 (Annals of surgery), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.